Preprint
Review

This version is not peer-reviewed.

V-Notes Sentinel Lymph Node Staging for Endometrial Cancer: a review.

A peer-reviewed article of this preprint also exists.

Submitted:

12 June 2025

Posted:

12 June 2025

You are already at the latest version

Abstract
Background/Objectives: Sentinel lymph node (SLN) mapping has become a standard approach in the surgical staging of early-stage endometrial cancer, aiming to reduce the morbidity associated with full lymphadenectomy while preserving diagnostic accuracy. Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) represents a novel, minimally invasive approach for SLN mapping that may offer specific benefits in terms of access, cosmetics, and recovery, particularly in select patient populations. Methods: A comprehensive literature search in the main databases was conducted for studies evaluating the use of v-notes for sentinel lymph node mapping in endometrial cancer patients. Results: Of the 12 included studies, three were observational cohort studies, while the remaining were case reports and series. The mean patient age was 59.6 years, with a majority being overweight or obese. V-NOTES was performed using both transperitoneal and retroperitoneal approaches, with indocyanine green (ICG) being the most commonly used tracer. The overall mean SLN detection rate was 98.19%, with a bilateral detection rate of 93.7%. The average operative time was 155 minutes, mean blood loss was 72.03 mL, and average hospital stay was 2.4 days. The complication rate was low (3.9%), with no conversions to laparotomy reported. Conclusions: V-NOTES appears to be a feasible and safe alternative for SLN mapping in early-stage endometrial cancer, with high detection rates and favorable perioperative outcomes. However, due to the limited number of comparative studies and small sample sizes, further prospective research is needed to establish its efficacy relative to traditional minimally invasive techniques and to determine optimal patient selection.
Keywords: 
;  ;  ;  

1. Introduction

Endometrial cancer ranks among the most prevalent malignancies in developed nations. Its rising incidence is primarily attributed to the concomitant increase in the prevalence of one of its most significant risk factors: obesity. [1]. Endometrial cancer surgical staging is a crucial step in determining the extent of disease spread and guiding treatment. Together with currently recommended preoperative work-up, it provides information about tumor grade, depth of myometrial invasion, and lymphatic involvement [2].
Lymph node evaluation is a crucial component of the staging process, offering valuable insights into the necessity of adjuvant treatment and the prognosis of the patient [3]. Traditionally, systematic lymphadenectomy includes the dissection of pelvic and para-aortic nodes extending up to the renal veins. A series of extensive retrospective studies have correlated systematic lymphadenectomy with extended survival, particularly in high-risk subtypes of endometrial cancer [4]. However, systematic lymphadenectomy was also associated with increased risks for the patients and an increased morbidity rates [5]. Their incidence varies in the literature, but it has been observed that a significant proportion of patients undergoing such a procedure present direct complications such as chronic lymphedema, lymphocysts, infections, or vascular and neurological lesions [6].
The sentinel node is defined as the first node involved in the drainage of the primary tumor to the regional lymph basin. To map it, a tracer is injected into the tumor area. It will migrate through the lymphatic vessels initially reaching the sentinel node which will be identified and surgically removed. If metastatic cells are not identified in this node, it can be assumed that the other non-sentinel nodes will also not contain metastatic cells [7]. As this concept became the standard for the surgical management of breast cancer and melanoma, the technique was also applied to other types of cancer, such as endometrial cancer Even though for many years research in this field on gynecologic cancers was limited to a small number of cases, the sentinel node technique has gained popularity recently due to the standardization of the method [2,8]. The risk of lymph node metastasis in endometrial cancer varies between < 5% and 40% depending on tumor grading, tumor histology, and myometrial invasion. Current recommendations of professional association guidelines regarding indications for sentinel node evaluation are: may be considered for staging purposes in patients with low- or intermediate-risk disease and should be performed in patients with intermediate-high or high-risk disease [9].
V-NOTES or Vaginal Natural Orifice Transluminal Endoscopic Surgery is an emerging minimally invasive surgical technique that uses a natural orifice, in this case, the vagina, for surgical access. This surgical approach has been associated with reduced blood loss, shorter operative time, shorter hospitalization time and a lower rate of postoperative morbidity as compared with classical laparoscopy [10]. In the last years, numerous publication have reported the use of V-NOTES technique for different types of gynecologic procedures [11]. Additionally, it has emerged as a superior technique for obese patients, as the conventional approach can prove to be challenging [12]. V-NOTES was applied for the first time for sentinel node mapping in endometrial cancer in 2016 by LeBlanc an a few years later Baekelandt described a new retroperitoneal approach [13,14].
This review presents a comprehensive summary of existing studies conducted on the V-NOTES technique employed for sentinel node mapping in endometrial cancer patients.

2. Materials and Methods

The present review aims to present the existing evidence regarding the use of V-NOTES techniques for sentinel node mapping in endometrial cancer patients.
  • Eligibility Criteria
    • Study design: Original articles including case studies, observational studies and randomized trials.
    • Method: Studies that involved performing the sentinel node mapping using V-NOTES technique.
    • Human involvement.
    • Language: Studies published in English.
    • Full text availability.
  • Information Sources and Search Strategy
The search for eligible studies was performed in medical databases such as PubMed, Scopus and Web of Science. Studies published between January 2016 (the year of the first report) and April 2025 were considered. The search strategy used multiple association of keywords: “V-NOTES”, “endometrial cancer”, “sentinel lymph node” and “sentinel node mapping”. Additionally, studies matching including criteria identified in the references of the studies found by the search strategy were included manually.
  • Study Selection
After the initial search, 35 articles were found. For each result, titles and abstracts were screened for eligibility. Articles that did not meet the inclusion criteria, were not relevant to the review’s purpose, or were duplicate studies, were excluded. In the next phase, the full text of the remaining 15 studies were reviewed and non-relevant articles were also eliminated. We mention that 2 of the articles, that were relevant for our review were available only as video articles and were exclude. Twelve (n = 12) articles were ultimately included in the review.
  • Data Extraction
Data relevant to the study objectives including first author, year of publication, design of the study, number of the patients included, pre-operative patient’s characteristics, operative parameters and outcomes of the SNL mapping including mean number of lymph nodes detected and detection rates were extracted, and a database was created in Jamovi software ver. 2.6.24 (https://www.jamovi.org, accessed on 15 April 2025).

3. Results

In total, a number of 12 articles were considered eligible to be included in the current review, from an initial search of 36 articles. The search strategy for this review is presented in Figure 1.

3.1. Characteristics of the Studies Included

Studies published between 2016, the year of the first report of V-NOTES technique in SLN mapping, and 2025 were included in this review. As this analysis is focusing on a emerging procedure we decided to include all study designs, including case reports and case series. Only three of the twelve studies were observational cohort studies where V-NOTES technique was compared with other procedures, while the other nine studies were case reports (n = 2) or case series (n = 7).

3.2. Characteristics of the Population Included

The twelve eligible studies included a total of 253 patients. The case report studies included between 4 and 64 patients, while the cohort studies included between 19 and 54 patients. The mean age of the population recruited in the studies was 59,6 years.
Several patient characteristics were observed across nearly all the included studies. With the exception of a single case report, body mass index (BMI) was reported in all studies, ranging between 24.2 kg/m2 and 31 kg/m2, with a mean of 27.21 kg/m2. The percentage of patients with a Body Mass Index (BMI) exceeding 25 kg/m2 (categorized as overweight or obese) included in the population for the studies was reported in eight of the twelve articles, ranging between 26% to 100%. Three studies included only overweight and obese patients. Another important factor for vaginal surgeries is the parity of the patient. Eight of the twelve studies reported the mean parity of the population included which ranged between 1.8 and 3.2 births. The final significant patient characteristic included in most of the studies was the percentage of patients who had prior abdominal surgery, reported in ten of the twelve studies. This variable ranged from 25% to 100%, with a mean of 48.7 %. Three of twelve studies had as exclusion criteria for their study population extensive adhesiogenic conditions. Patient’s characteristics are presented in Table 1.

3.3. Histological and Imaging Characteristics

Four variables were observed in most of the studies. These were pre-operative variables. Histology of biopsy specimens were mentioned in nine of the twelve studies. Six studies included only patients with endometrioid carcinoma, two studies included endometrioid carcinoma and complex atypical hyperplasia and one study included endometrial tumors of all histological types and also complex atypical hyperplasia. Grading of the tumor was available for the same nine studies. Eight of those nine studies included tumors of low grade (G1 and G2) and one study also include high-grade (G3) tumors.
In nine of the twelve studies, preoperative imaging information (ultrasound and/or MRI) was available. The details provided varied, ranging from a general mention of the procedure being performed to a detailed description of specific findings, such as tumor dimensions, localization, absence of lymphatic or distant metastases.
Staging was available in ten studies, either explicitly mentioned or indirectly inferred by providing sufficient data to determine the stage of tumors. Consequently, nine studies exclusively included patients with stage I tumors, whereas the study that also involved G3 tumors included patients with stage II tumors, specifically stage IIA. Histological and imaging characteristics are presented in Table 2.

3.4. Surgical Outcomes

All included patients underwent a total hysterectomy with bilateral salpingo-oophorectomy as the primary procedure. SNL mapping was performed using the V-NOTES technique by transperitoneal approach in five cases and the newer retroperitoneal approach in eight cases. Ten of the twelve studies utilized indocyanine green (ICG) as the tracer, while one study combined ICG with carbon nanoparticles (CNPs), and another utilized only CNPs. The laparoscopic conversion rate varied between 0% and 14%, and no conversion to laparotomy was necessary in any case. The mean operation time available for eleven studies was 155 minutes. In ten of the twelve studies, the mean blood loss was mentioned, and it was an average of 72.03 milliliters. Four studies reported the difference between the pre-operative and post-operative hemoglobin value, with a mean of minus 1.3 grams per deciliter. No blood transfusion was necessary in any of the studies included. Post-operative hospital stay was available in ten studies, with a mean of 2.4 days. Surgical outcomes are presented in Table 3.

3.5. SNL Mapping Outcomes

The mean success rate was 96.4 %, with six studies reporting a success rate of 100%. Mean total lymph nodes identified was reported in nine studies and ranged between 2 and 12.5 lymph nodes. Mean right and left lymph nodes was reported in seven studies and ranged between 1 and 5.7 nodes for the right side and 1 to 6.2 nodes for the left side. Overall detection rate was available for ten of the twelve studies and had a mean of 98.19 %. Bilateral detection rate had a mean of 93.7% and unilateral detection rate had a mean of 6.7 %. When comparing detection rate based on the SNL mapping approach no significant difference is observed (p = 0.67). The distribution of the SNL by anatomic location was available in only six studies: external iliac 10.5 - 77.3%, obturator 57.3 – 84 %, internal iliac 2 – 4.8 %, common iliac 2.9 – 22.7 % and presacral 0.3 – 0.9 %. SNL mapping outcomes are presented in Table 4.

3.6. Complications and Follow-Up

Complications during surgical procedures were reported in eleven of the twelve studies. Complications were encountered in four studies, involving ten patients out of the 253 patients included in all the studies (3.9%). The most frequent complications were vascular injuries with active bleeding or hematoma formation in six patients, followed by bladder injuries in four patients.

4. Discussion

This review aimed to assess the current evidence regarding the use of the vaginal natural orifice transluminal endoscopic surgery (V-NOTES) technique for sentinel lymph node (SLN) mapping in endometrial cancer staging. As a relatively novel approach, V-NOTES is gaining traction for its minimally invasive nature and potential benefits in gynecologic oncology. The inclusion of diverse study designs, including case reports and case series, reflects the emergent nature of this technique and the still limited but growing body of literature.
Our review included 12 studies with a total of 253 patients, demonstrating that although the overall sample size remains modest, early clinical experiences with V-NOTES in SLN staging are increasingly reported. The patients’ characteristics that were encountered in almost all the studies included, highlights the applicability of V-NOTES in real-world settings, including in populations often considered technically challenging for traditional laparoscopy. Obesity is a well-established risk factor for endometrial cancer, accounting for a substantial proportion of patients who necessitate surgical intervention for this disease [27]. The increased abdominal wall thickness in these individuals can complicate conventional open or laparoscopic surgical procedures, thereby elevating the likelihood of surgical complications and adverse outcomes. Furthermore, the majority of these obese patients also exhibit multiple comorbidities that will increase the anesthesia risks, necessitating shorter operative times. The V-NOTES technique represents an alternative for these individuals [28]. In our review, the mean body mass index (BMI) of the patients included was 27.21 kg/m2, with overweight and obese patients comprising 26 to 100% of the study populations. A notable advantage of the V-NOTES technique over abdominal surgery is its suitability for patients with prior abdominal surgeries and the potential for extensive peritoneal adhesions, as it avoids the need to pass through the abdominal wall. Although some highly adhesiogenic conditions or procedures, such as rectovaginal endometriosis or pelvic radiotherapy, have been considered contraindications to V-NOTES in a recent experts’ consensus, procedures like prior cesarean section, total hysterectomy, or sacrocolpopexy did not reach a general agreement [29]. In our review, history of abdominal surgery was a pre-operative variable in ten of the twelve studies and ranged between 25 and 100% of the population included.
The most frequent histological characteristics encountered in the studies included were endometrioid carcinoma type, low-grade (G1 and G2) tumors and patients with stage I disease. The predominance of these characteristics of endometrial cancers in the studies is consistent with current guidelines recommending sentinel node staging primarily in low- to intermediate-risk cases [9].
The surgical characteristics demonstrate encouraging operative outcomes and highlight the reported advantages of the V-NOTES technique. The mean operation time (155 minutes) and low blood loss (72.03 mL), coupled with a low rate of conversion to laparoscopy (up to 14%) and no conversions to laparotomy, suggest that V-NOTES can be performed safely in selected patients. Also, the average hospital stay of 2.4 days is consistent with the benefits expected from minimally invasive approaches. The effectiveness and safety of V-NOTES procedure in benign gynecologic surgery has been reported in numerous studies. In a recent systematic review and meta-analysis, V-NOTES had significantly lower operative times, shorter hospital stay, post-operative pain scores and similar estimated blood loss, hemoglobin change in day 1 compared with conventional laparoscopy [30]. Data concerning V-NOTES in gynecologic malignancy is poor. Most reports involve endometrial cancer and only a few cases reports on its use in ovarian and cervical cancer [31,32,33].
While all the patients included in the review had total hysterectomy with bilateral salpingo-oophorectomy as the primary procedure the SNL mapping was performed either through a transperitoneal approach or through a retroperitoneal approach. These techniques differ in surgical access, anatomical exposure, and procedural complexity. The transperitoneal approach enters the peritoneal cavity directly through a posterior colpotomy offering a safety and efficacy comparable with conventional laparoscopy [26]. Its disadvantages are the need of bowel mobilization, a more extensive dissection of peritoneal surfaces and suboptimal visualization of the caudal part. In comparation, retroperitoneal approach, first described by Baekeland in 2019, creates a retroperitoneal space without opening the peritoneal cavity providing a better visualization of the lymphatic system in a more logical fashion on a caudal to cranial direction. Its main disadvantage is the higher technical skill required [14]. In our review the retroperitoneal approach was the most used (eight studies).
Of particular note, we mention the high detection rates achieved through V-NOTES. A mean overall SLN detection rate of 98.19%, with bilateral detection in 93.7% of cases, compares favorably to traditional laparoscopic or robotic techniques. For SNL mapping by conventional laparoscopy and robotic laparoscopy an overall detection rate of 62 % to 96 % is reported. However, the bilateral detection rate is lower with 34 % to 88 % [3]. In our review, we highlight that the highest detection rates, reaching 100%, were observed in studies involving one or under ten patients. This observation may contribute to the overall detection rate observed. Those results suggests that, with experienced practitioners, V-NOTES can effectively achieve oncologically appropriate nodal staging. However, as of our knowledge, no studies have been published that explore the learning curve associated with V-NOTES SNL mapping. Although one of the most important advantages of the V-NOTES technique is the approach following the direction of lymph drainage only half of the studies reported the anatomical distribution of the sentinel lymph nodes identified. The most frequent site was the obturator area followed by external iliac area, while the most infrequent site was the presacral area. This observation is similar with the laparoscopic approach with a report of 38-70% for the external iliac area and 13-26% for the obturator area [3,34,35]. However, the obturator area is more favored than external iliac area by the V-NOTES approach, especially with a retroperitoneal technique highlighting the better accessibility from a caudal to a cranial direction [20]. The most commonly used tracer was indocyanine green (ICG), consistent with broader literature supporting its superior lymphatic mapping capabilities [36]. Emerging tracer combinations, such as ICG with carbon nanoparticles, warrant further study.
Complication rates were low, with only 3.9% of patients experiencing intraoperative adverse events. Vascular injuries with hemorrhage and bladder injuries were the most frequently encountered issues. In a large retrospective study by Hou on V-NOTES for gynecological pathologies, the reported complication rate was similar with 4.4% [37]. This rate is comparable with reported complication rate for the other minimally invasive techniques such as laparoscopy with 5.6% or robotic surgery with 3.6% [38,39]. In Hou’s study, the most frequent complication besides hemorrhage was rectal injury, which occurred exclusively in patients with deep endometriosis. This observation corroborates the recommendation of the 2021 V-NOTES consensus to refrain from performing this technique in the presence of deep endometriosis, underscoring the significance of case selection. [29]. Also, these complications highlight the learning curve associated with V-NOTES, especially in lymphatic mapping, and emphasize the need for proper training during the initial adoption phase.
This review is limited by the heterogeneity and mostly retrospective nature of the included studies. Only three were comparative cohort studies, which restricts our ability to draw definitive conclusions about the comparative efficacy or safety of V-NOTES relative to other surgical approaches. Moreover, the inclusion of multiple small case series may introduce selection bias, as these often report the most favorable outcomes during the learning phase.
Despite these limitations, the aggregated evidence suggests that V-NOTES represents a feasible and effective alternative for SLN staging in endometrial cancer. As surgical expertise grows and more robust comparative data become available, V-NOTES may assume a more prominent role in the minimally invasive staging alternatives.

5. Conclusions

The findings of this review suggest that V-NOTES is a promising technique for sentinel lymph node (SLN) staging in endometrial cancer, offering high detection rates, low complication rates, and favorable perioperative outcomes. While current evidence, drawn from a mix of case reports, case series, and a few observational studies, supports the safety and efficacy of V-NOTES, the limited number and heterogeneity of available studies highlight the need for larger, prospective, and comparative trials. Standardization of technique, broader reporting of long-term oncologic outcomes, and further exploration of optimal patient selection criteria will be essential in validating the role of V-NOTES in routine clinical practice.

Author Contributions

Conceptualization, M.N. and L.P.; methodology, L.P.; software, C.S.; validation, A.M.F.; formal analysis, F.O.; investigation, F.O.; resources, M.N.; data curation, O.B.; writing—original draft preparation, M.N. and O.B.; writing—review and editing, M.N. and O.B.; visualization, L.P.; supervision, L.P.; project administration, O.B.; funding acquisition, M.N. All authors have read and agreed to the published version of the manuscript.

Funding

We would like to acknowledge VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA for their support in covering the costs of publication for this research paper.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest

Abbreviations

The following abbreviations are used in this manuscript:
V-NOTES Vaginal Natural Orifice Transluminal Endoscopic Surgery
SLN Sentinel Lymph Node
ICG Indocyanine green

References

  1. Rahib, L.; Smith, B.D.; Aizenberg, R.; Rosenzweig, A.B.; Fleshman, J.M.; Matrisian, L.M. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Research 2014, 74, 2913–2921. [Google Scholar] [CrossRef] [PubMed]
  2. Oaknin, A.; Bosse, T.J.; Creutzberg, C.L.; Giornelli, G.; Harter, P.; Joly, F.; Lorusso, D.; Marth, C.; Makker, V.; Mirza, M.R.; et al. Endometrial Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Annals of Oncology 2022, 33, 860–877. [Google Scholar] [CrossRef]
  3. Holloway, R.W.; Abu-Rustum, N.R.; Backes, F.J.; Boggess, J.F.; Gotlieb, W.H.; Jeffrey Lowery, W.; Rossi, E.C.; Tanner, E.J.; Wolsky, R.J. Sentinel Lymph Node Mapping and Staging in Endometrial Cancer: A Society of Gynecologic Oncology Literature Review with Consensus Recommendations. Gynecologic Oncology 2017, 146, 405–415. [Google Scholar] [CrossRef]
  4. Todo, Y.; Kato, H.; Kaneuchi, M.; Watari, H.; Takeda, M.; Sakuragi, N. Survival Effect of Para-Aortic Lymphadenectomy in Endometrial Cancer (SEPAL Study): A Retrospective Cohort Analysis. The Lancet 2010, 375, 1165–1172. [Google Scholar] [CrossRef]
  5. Mariani, A.; Dowdy, S.C.; Cliby, W.A.; Gostout, B.S.; Jones, M.B.; Wilson, T.O.; Podratz, K.C. Prospective Assessment of Lymphatic Dissemination in Endometrial Cancer: A Paradigm Shift in Surgical Staging. Gynecologic Oncology 2008, 109, 11–18. [Google Scholar] [CrossRef]
  6. Ducie, J.A.; Eriksson, A.G.Z.; Ali, N.; McGree, M.E.; Weaver, A.L.; Bogani, G.; Cliby, W.A.; Dowdy, S.C.; Bakkum-Gamez, J.N.; Soslow, R.A.; et al. Comparison of a Sentinel Lymph Node Mapping Algorithm and Comprehensive Lymphadenectomy in the Detection of Stage IIIC Endometrial Carcinoma at Higher Risk for Nodal Disease. Gynecologic Oncology 2017, 147, 541–548. [Google Scholar] [CrossRef]
  7. El-Ghobashy, A.E.; Saidi, S.A. Sentinel Lymph Node Sampling in Gynaecological Cancers: Techniques and Clinical Applications. European Journal of Surgical Oncology (EJSO) 2009, 35, 675–685. [Google Scholar] [CrossRef]
  8. Khoury-Collado, F.; Abu-Rustum, N.R. Lymphatic Mapping in Endometrial Cancer: A Literature Review of Current Techniques and Results. International Journal of Gynecological Cancer 2008, 18, 1163–1168. [Google Scholar] [CrossRef]
  9. Concin, N.; Matias-Guiu, X.; Vergote, I.; Cibula, D.; Mirza, M.R.; Marnitz, S.; Ledermann, J.; Bosse, T.; Chargari, C.; Fagotti, A.; et al. ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma. International Journal of Gynecological Cancer 2021, 31, 12–39. [Google Scholar] [CrossRef]
  10. Ferro, R.; Hurni, Y.; Seidler, S.; Huber, D. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Gynecological Emergencies. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 2023, 20, 100261. [Google Scholar] [CrossRef]
  11. Li, C.; Hua, K. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Gynecologic Surgeries: A Systematic Review. Asian Journal of Surgery 2020, 43, 44–51. [Google Scholar] [CrossRef] [PubMed]
  12. Bouchez, M.-C.; Delporte, V.; Delplanque, S.; Leroy, M.; Vandendriessche, D.; Rubod, C.; Cosson, M.; Giraudet, G. vNOTES Hysterectomy: What about Obese Patients? Journal of Minimally Invasive Gynecology 2023, 30, 569–575. [Google Scholar] [CrossRef] [PubMed]
  13. Leblanc, E.; Narducci, F.; Bresson, L.; Hudry, D. Fluorescence-Assisted Sentinel (SND) and Pelvic Node Dissections by Single-Port Transvaginal Laparoscopic Surgery, for the Management of an Endometrial Carcinoma (EC) in an Elderly Obese Patient. Gynecologic Oncology 2016, 143, 686–687. [Google Scholar] [CrossRef] [PubMed]
  14. Baekelandt, J.F. New Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery Approach to Sentinel Node for Endometrial Cancer: A Demonstration Video. Journal of Minimally Invasive Gynecology 2019, 26, 1231–1232. [Google Scholar] [CrossRef]
  15. Baekelandt, J.; Jespers, A.; Huber, D.; Badiglian-Filho, L.; Stuart, A.; Chuang, L.; Ali, O.; Burnett, A. vNOTES Retroperitoneal Sentinel Lymph Node Dissection for Endometrial Cancer Staging: First Multicenter, Prospective Case Series. Acta Obstet Gynecol Scand 2024, 103, 1311–1317. [Google Scholar] [CrossRef]
  16. Comba, C.; Karakas, S.; Erdogan, S.V.; Demir, O.; Şimşek, E.; Karasabanoglu, F.; Demirayak, G.; Ozdemir, I.A. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (VNOTES) Retroperitoneal Sentinel Lymph Node BIOPSY Compared with Conventional Laparoscopy in Patients with Endometrial Cancer. Surgical Oncology 2024, 55, 102099. [Google Scholar] [CrossRef]
  17. Comba, C.; Demirayak, G.; Simsek, C.; Atas, B.S.; Özdemir, İ.A. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (VNOTES) Total Retroperitoneal Sentinel Lymph Node Biopsy for an Endometrial Cancer Patient with Prior Colon Cancer Surgery. International Journal of Gynecological Cancer 2021, 31, 1386–1387. [Google Scholar] [CrossRef]
  18. Deng, L.; Liu, Y.; Yao, Y.; Deng, Y.; Tang, S.; Sun, L.; Wang, Y. Efficacy of Vaginal Natural Orifice Transluminal Endoscopic Sentinel Lymph Node Biopsy for Endometrial Cancer: A Prospective Multicenter Cohort Study. International Journal of Surgery 2023. [Google Scholar] [CrossRef]
  19. Huber, D.; Hurni, Y. Sentinel Node Biopsy for Endometrial Cancer by Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery: A Preliminary Study. Front. Surg. 2022, 9, 907548. [Google Scholar] [CrossRef]
  20. Huber, D.; Hurni, Y. Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial Cancer: Analysis of 124 Lymph Nodes. Journal of Minimally Invasive Gynecology 2024, 31, 438–444. [Google Scholar] [CrossRef]
  21. Lee, C.-L.; Liu, H.-M.; Khan, S.; Lee, P.-S.; Huang, K.-G.; Yen, C.-F. Vaginal Natural Orifice Transvaginal Endoscopic Surgery (vNOTES) Surgical Staging for Endometrial Carcinoma: The Feasibility of an Innovative Approach. Taiwanese Journal of Obstetrics and Gynecology 2022, 61, 345–352. [Google Scholar] [CrossRef] [PubMed]
  22. Matak, L.; Šimičević, M.; Dukić, B.; Matak, M.; Baekelandt, J. vNOTES Surgical Staging for Endometrial Carcinoma in Overweight Patients: A Case Series. Arch Gynecol Obstet 2024, 309, 2829–2832. [Google Scholar] [CrossRef] [PubMed]
  23. Mathey, M.-P.; Romito, F.; Huber, D.E. Retroperitoneal Sentinel Lymph Node Biopsy by Vaginally Assisted Natural Orifices Endoscopic Transluminal Endoscopic Surgery in Early Stage Endometrial Cancer: Description of Technique and Surgeon’s Perspectives after the First Experience. Case Rep Oncol 2022, 15, 291–299. [Google Scholar] [CrossRef] [PubMed]
  24. Şimşek, E.; Yıldız, Ö.A.; Gündüz, S.; Karakaş, S.; Yaşar, L. vNOTES Scarless and Painless Endometrial Cancer Staging Surgery. J of Obstet and Gynaecol 2024, 50, 1965–1970. [Google Scholar] [CrossRef]
  25. Tantitamit, T.; Lee, C.-L. Application of Sentinel Lymph Node Technique to Transvaginal Natural Orifices Transluminal Endoscopic Surgery in Endometrial Cancer. Journal of Minimally Invasive Gynecology 2019, 26, 949–953. [Google Scholar] [CrossRef]
  26. Wang, Y.; Deng, L.; Tang, S.; Dou, Y.; Yao, Y.; Li, Y.; Deng, Y.; Chen, Y.; Liang, Z. vNOTES Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Description of Technique and Perioperative Outcomes. Journal of Minimally Invasive Gynecology 2021, 28, 1254–1261. [Google Scholar] [CrossRef]
  27. Onstad, M.A.; Schmandt, R.E.; Lu, K.H. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. JCO 2016, 34, 4225–4230. [Google Scholar] [CrossRef]
  28. Wang, F.; Liu, Y.; Xing, Y.; Wang, D.; Bai, X.; Li, L.; Ma, C.; Sun, Y.; Bai, Y.; Wang, L. Clinical Efficacy and Safety Study of vNOTES for Benign Ovarian Tumors in Obese Patients. Sci Rep 2025, 15, 4609. [Google Scholar] [CrossRef]
  29. Kapurubandara, S.; Lowenstein, L.; Salvay, H.; Herijgers, A.; King, J.; Baekelandt, J. Consensus on Safe Implementation of Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES). European Journal of Obstetrics & Gynecology and Reproductive Biology 2021, 263, 216–222. [Google Scholar] [CrossRef]
  30. Marchand, G.J.; Masoud, A.T.; Ulibarri, H.; Arroyo, A.; Moir, C.; Blanco, M.; Herrera, D.G.; Hamilton, B.; Ruffley, K.; Petersen, M.; et al. Systematic Review and Meta-Analysis of Vaginal Natural Orifice Transluminal Endoscopic Surgery vs Laparoscopic Hysterectomy. AJOG Global Reports 2024, 4, 100320. [Google Scholar] [CrossRef]
  31. Hurni, Y.; Romito, F.; Huber, D. Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Surgical Staging of Early-Stage Ovarian Cancers: A Report of Two Cases. Front. Surg. 2022, 9, 833126. [Google Scholar] [CrossRef] [PubMed]
  32. Kellerhals, G.; Nef, J.; Hurni, Y.; Huber, D. Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Early-Stage Ovarian Cancer and Borderline Ovarian Tumors: A Case Series. Front. Surg. 2025, 12, 1542486. [Google Scholar] [CrossRef] [PubMed]
  33. Hurni, Y.; Huber, D.E. Sentinel Node Biopsy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery in a Patient with Early-Stage Cervical Cancer: A Case Report. Case Rep Oncol 2022, 15, 547–552. [Google Scholar] [CrossRef]
  34. Restaino, S.; Buda, A.; Puppo, A.; Capozzi, V.A.; Sozzi, G.; Casarin, J.; Gallitelli, V.; Murgia, F.; Vizzielli, G.; Baroni, A.; et al. Anatomical Distribution of Sentinel Lymph Nodes in Patients with Endometrial Cancer: A Multicenter Study. International Journal of Gynecological Cancer 2022, 32, 517–524. [Google Scholar] [CrossRef]
  35. Sozzi, G.; Fanfani, F.; Berretta, R.; Capozzi, V.A.; Uccella, S.; Buono, N.; Giallombardo, V.; Di Donna, M.C.; Monterossi, G.; Restaino, S.; et al. Laparoscopic Sentinel Node Mapping with Intracervical Indocyanine Green Injection for Endometrial Cancer: The SENTIFAIL Study – a Multicentric Analysis of Predictors of Failed Mapping. International Journal of Gynecological Cancer 2020, 30, 1713–1718. [Google Scholar] [CrossRef]
  36. Laufer, J.; Scasso, S.; Papadia, A. Different Tracers for Sentinel Node Detection in Gynecologic Oncology. Current Opinion in Oncology 2024, 36, 371–375. [Google Scholar] [CrossRef]
  37. Hou, Q.; Li, X.; Li, Y.; Zhang, Q.; Liu, T.; Huang, L.; Gong, Z.; Feng, D.; Gu, D.; Lin, Y.; et al. Analysis and Suggestions on the Complications in 2000 Cases of Transvaginal Natural Orifice Transluminal Endoscopic Surgery: Can It Be a Conventional Surgery? Intl J Gynecology & Obste 2024, 164, 541–549. [Google Scholar] [CrossRef]
  38. DeNardis, S.A.; Holloway, R.W.; Bigsby, G.E.; Pikaart, D.P.; Ahmad, S.; Finkler, N.J. Robotically Assisted Laparoscopic Hysterectomy versus Total Abdominal Hysterectomy and Lymphadenectomy for Endometrial Cancer. Gynecologic Oncology 2008, 111, 412–417. [Google Scholar] [CrossRef]
  39. Kaya, A.C.; Radosa, M.P.; Zimmermann, J.S.M.; Stotz, L.; Findeklee, S.; Hamza, A.; Sklavounos, P.; Takacs, F.Z.; Wagenpfeil, G.; Radosa, C.G.; et al. Intraoperative and Postoperative Complications of Gynecological Laparoscopic Interventions: Incidence and Risk Factors. Arch Gynecol Obstet 2021, 304, 1259–1269. [Google Scholar] [CrossRef]
Figure 1. PRIMA chart.
Figure 1. PRIMA chart.
Preprints 163442 g001
Table 1. Characteristics of the population included.
Table 1. Characteristics of the population included.
Author Year Design Patients Mean age Mean BMI (kg/m2) > 25 kg/m2 (%) Mean parity Prior surgery (%)
Baekeland [15] 2024 Case series 64 69.5 26 34 - 38
Comba [16] 2024 Cohort 19 59.4 29 100 2 -
Comba [17] 2021 Case report 1 46 27.4 100 2 100
Deng [18] 2023 Cohort 57 51.46 26.25 78.95 2 31.58
Huber [19] 2022 Case series 7 68 26.4 57 2.2 57
Huber [20] 2024 Case series 34 68 27.3 - - 58.8
Lee [21] 2022 Case series 15 52.8 27.8 26 1.8 26
Matak [22] 2024 Case series 4 67 28.45 100 2 25
Mathey [23] 2022 Case report 1 64 - - - -
Simsek [24] 2024 Case series 24 56.5 31 - - 67
Tantitamit [25] 2018 Case series 4 60.3 25.6 75 3.2 50
Wang [26] 2021 Cohort 23 53 24.2 - 2 34
Table 2. Pre-operative histological and imaging characteristics.
Table 2. Pre-operative histological and imaging characteristics.
Author Year Tumor
histology
Tumor grading Imaging (US/MRI) Staging
Baekeland [15] 2024 All types and Complex Atypical Hyperplasia 1-3 No I-II
Comba [16] 2024 - - Yes -
Comba [17] 2021 Endometrioid 2 Yes I
Deng [18] 2023 Endometrioid - Yes I
Huber [19] 2022 Endometrioid and Complex Atypical Hyperplasia 1-2 Yes I
Huber [20] 2024 Endometrioid and Complex Atypical Hyperplasia - Yes I
Lee [21] 2022 Endometrioid 1-2 Yes I
Matak [22] 2024 Endometrioid 1 No I
Mathey [23] 2022 Endometrioid 1 Yes I
Simsek [24] 2024 - - Yes -
Tantitamit [25] 2018 - - No I
Wang [26] 2021 Endometrioid 1-2 Yes I
Table 3. Surgical outcomes.
Table 3. Surgical outcomes.
Author Year SLN approach Tracer Mean op. Time Estimated blood loss (ml) Pre-op-Post-op HB (g/dl)
Baekeland [15] 2024 Retroperitoneal ICG 126 80 -1
Comba [16] 2024 Retroperitoneal ICG 208.4 76.3 -1.5
Comba [17] 2021 Retroperitoneal ICG 180 20 -
Deng [18] 2023 Transperitoneal ICG, CNP 132.35 75 -
Huber [19] 2022 Retroperitoneal ICG 113 20 -
Huber [20] 2024 Retroperitoneal ICG - - -
Lee [21] 2022 Transperitoneal ICG 231.4 122 -1.44
Matak [22] 2024 Retroperitoneal ICG 169 - -1.9
Mathey [23] 2022 Retroperitoneal ICG 113 100 -
Simsek [24] 2024 Retroperitoneal ICG 125 70 -
Tantitamit [25] 2018 Transperitoneal ICG 182.7 67 -0.57
Wang [26] 2021 Transperitoneal CNP 132.3 90 -1
Table 4. SNL mapping outcomes.
Table 4. SNL mapping outcomes.
Author Year Succes rate (%) Total LN Mean Right LN Mean Left LN Overall DR (%) Bilateral DR (%) Unilateral DR (%)
Baekeland [15] 2024 98.5 3 - - 100 97 3
Comba [16] 2024 94.8 - - - 94.8 - -
Comba [17] 2021 100 - - - 100 - -
Deng [18] 2023 81.5 - - - 94.7 82.4 12.3
Huber [19] 2022 100 3.1 1.2 1.8 100 100 -
Huber [20] 2024 91.2 3 1 1 97.1 91.2 5.9
Lee [21] 2022 100 5.3 2.3 1.9 100 - -
Matak [22] 2024 100 12.5 5.7 6.2 100 - -
Mathey [23] 2022 100 3 1 2 100 100 -
Simsek [24] 2024 96 2 1 1 96 91 4
Tantitamit [25] 2018 100 8.5 5 2.5 100 100 -
Wang [26] 2021 95.7 5 - - 95.7 87 8.7
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated